{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T21:08:09Z","timestamp":1778620089808,"version":"3.51.4"},"reference-count":57,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T00:00:00Z","timestamp":1684108800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["45316004"],"award-info":[{"award-number":["45316004"]}],"id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpain.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pain"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.jpain.2023.05.003","type":"journal-article","created":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T09:46:45Z","timestamp":1684835205000},"page":"1696-1711","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Nocebo Hyperalgesia in Patients With Fibromyalgia and Healthy Controls: An Experimental Investigation of Conditioning and Extinction Processes at Baseline and 1-Month Follow-up"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0834-2913","authenticated-orcid":false,"given":"Merve","family":"Karacaoglu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaya J.","family":"Peerdeman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mattijs E.","family":"Numans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martha R.","family":"Stolk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone","family":"Meijer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Regine","family":"Klinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dieuwke S.","family":"Veldhuijzen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4575-0895","authenticated-orcid":false,"given":"Henri\u00ebt","family":"van Middendorp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea W.M.","family":"Evers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpain.2023.05.003_bib1","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1159\/000490354","article-title":"Implications of placebo and nocebo effects for clinical practice: Expert consensus","volume":"87","author":"Evers","year":"2018","journal-title":"Psychother Psychosom"},{"key":"10.1016\/j.jpain.2023.05.003_bib2","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1001\/jama.287.5.622","article-title":"Nonspecific medication side effects and the nocebo phenomenon","volume":"287","author":"Barsky","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.jpain.2023.05.003_bib3","doi-asserted-by":"crossref","first-page":"12014","DOI":"10.1523\/JNEUROSCI.2947-06.2006","article-title":"The biochemical and neuroendocrine bases of the hyperalgesic nocebo effect","volume":"26","author":"Benedetti","year":"2006","journal-title":"J Neurosci"},{"key":"10.1016\/j.jpain.2023.05.003_bib4","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/bs.irn.2018.01.011","article-title":"Using learning strategies to inhibit the Nocebo effect","volume":"138","author":"Quinn","year":"2018","journal-title":"Int. Rev\u00a0Neurobiol"},{"key":"10.1016\/j.jpain.2023.05.003_bib5","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1097\/j.pain.0000000000001861","article-title":"Learning mechanisms in nocebo hyperalgesia: The role of conditioning and extinction processes","volume":"161","author":"Thomaidou","year":"2020","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2023.05.003_bib6","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1097\/PSY.0b013e3182294a50","article-title":"The nocebo effect and its relevance for clinical practice","volume":"73","author":"Colloca","year":"2011","journal-title":"Psychosom Med"},{"key":"10.1016\/j.jpain.2023.05.003_bib7","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0304-3959(97)03346-0","article-title":"Blockade of nocebo hyperalgesia by the cholecystokinin antagonist proglumide","volume":"71","author":"Benedetti","year":"1997","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2023.05.003_bib8","doi-asserted-by":"crossref","first-page":"4315","DOI":"10.1523\/JNEUROSCI.23-10-04315.2003","article-title":"Conscious expectation and unconscious conditioning in analgesic, motor, and hormonal placebo\/nocebo responses","volume":"23","author":"Benedetti","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.jpain.2023.05.003_bib9","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1159\/000501385","article-title":"Positive treatment expectancies reduce clinical pain and perceived limitations in movement ability despite increased experimental pain: A randomized controlled trial on sham opioid infusion in patients with chronic back pain","volume":"88","author":"Schmitz","year":"2019","journal-title":"Psychother Psychosom"},{"key":"10.1016\/j.jpain.2023.05.003_bib10","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0304-3959(03)00073-3","article-title":"The contributions of suggestion, desire, and expectation to placebo effects in irritable bowel syndrome patients. An\u00a0empirical\u00a0investigation","volume":"105","author":"Vase","year":"2003","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2023.05.003_bib11","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.jpain.2015.06.012","article-title":"Nocebo hyperalgesia, partial reinforcement, and extinction","volume":"16","author":"Colagiuri","year":"2015","journal-title":"J Pain"},{"key":"10.1016\/j.jpain.2023.05.003_bib12","first-page":"1","article-title":"Efficacy of open-label counterconditioning for reducing nocebo effects on pressure pain","volume":"00","author":"Meijer","year":"2023","journal-title":"Eur J Pain"},{"key":"10.1016\/j.jpain.2023.05.003_bib13","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/j.pain.2014.04.016","article-title":"The magnitude of nocebo effects in pain: A meta-analysis","volume":"155","author":"Petersen","year":"2014","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2023.05.003_bib14","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/s41584-020-00506-w","article-title":"Fibromyalgia: An update on clinical characteristics, aetiopathogenesis and treatment","volume":"16","author":"Sarzi-Puttini","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jpain.2023.05.003_bib15","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1155\/2013\/742510","article-title":"Patients\u2019 and professionals\u2019 views on managing fibromyalgia","volume":"18","author":"Briones-Vozmediano","year":"2013","journal-title":"Pain Res Manag"},{"key":"10.1016\/j.jpain.2023.05.003_bib16","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1177\/1054773806291853","article-title":"Individuals\u2019 descriptions of living with fibromyalgia","volume":"15","author":"Cunningham","year":"2006","journal-title":"Clin Nurs Res"},{"key":"10.1016\/j.jpain.2023.05.003_bib17","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.amjmed.2014.08.031","article-title":"Bad is more powerful than good: The nocebo response in medical consultations","volume":"128","author":"Greville-Harris","year":"2015","journal-title":"Am J Med"},{"key":"10.1016\/j.jpain.2023.05.003_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fpsyg.2016.01270","article-title":"An integrative review of the influence of expectancies on pain","volume":"7","author":"Peerdeman","year":"2016","journal-title":"Front Psychol"},{"key":"10.1016\/j.jpain.2023.05.003_bib19","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s00702-019-02104-x","article-title":"Nocebo and the contribution of psychosocial factors to the generation of pain","volume":"127","author":"Benedetti","year":"2020","journal-title":"J Neural Transm"},{"key":"10.1016\/j.jpain.2023.05.003_bib20","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1097\/j.pain.0000000000000093","article-title":"Learning mechanisms in pain chronification-teachings from placebo research","volume":"156","author":"Ingvar","year":"2015","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2023.05.003_bib21","article-title":"How to prevent, minimize, or extinguish nocebo effects in pain: A narrative review on mechanisms, predictors, and interventions","volume":"4","author":"Manai","year":"2019","journal-title":"Pain Rep"},{"key":"10.1016\/j.jpain.2023.05.003_bib22","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1002\/j.1532-2149.2013.00300.x","article-title":"Fear-learning deficits in subjects with fibromyalgia syndrome?","volume":"17","author":"Jenewein","year":"2013","journal-title":"Eur J Pain"},{"key":"10.1016\/j.jpain.2023.05.003_bib23","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1097\/j.pain.0000000000001207","article-title":"Reduced selective learning in patients with fibromyalgia vs healthy controls","volume":"159","author":"Meulders","year":"2018","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2023.05.003_bib24","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.jpain.2015.09.007","article-title":"Comparing counterconditioning and extinction as methods to reduce fear of movement-related pain","volume":"16","author":"Meulders","year":"2015","journal-title":"J Pain"},{"key":"10.1016\/j.jpain.2023.05.003_bib25","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jpain.2016.10.004","article-title":"Extinction of fear generalization: A comparison between fibromyalgia patients and healthy control participants","volume":"18","author":"Meulders","year":"2017","journal-title":"J Pain"},{"key":"10.1016\/j.jpain.2023.05.003_bib26","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1093\/abm\/kay071","article-title":"The influence of side effect information framing on nocebo effects","volume":"53","author":"Faasse","year":"2019","journal-title":"Ann Behav Med"},{"key":"10.1016\/j.jpain.2023.05.003_bib27","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3758\/BF03193146","article-title":"G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences","volume":"39","author":"Faul","year":"2007","journal-title":"Behav Res Methods"},{"key":"10.1016\/j.jpain.2023.05.003_bib28","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/da.22249","article-title":"What is the threshold for a clinically relevant effect? The case of major depressive disorders","volume":"31","author":"Cuijpers","year":"2014","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.jpain.2023.05.003_bib29","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/s11926-001-0008-3","article-title":"The role of gender in fibromyalgia syndrome","volume":"3","author":"Yunus","year":"2001","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.jpain.2023.05.003_bib30","first-page":"238","article-title":"Intelligence and age in a Dutch sample","volume":"8","author":"Verhage","year":"1965","journal-title":"Hum Dev"},{"key":"10.1016\/j.jpain.2023.05.003_bib31","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.3899\/jrheum.100594","article-title":"Fibromyalgia criteria and severity scales for clinical and epidemiological studies: A modification of the ACR preliminary diagnostic criteria for fibromyalgia","volume":"38","author":"Wolfe","year":"2011","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jpain.2023.05.003_bib32","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0304-3959(03)00204-5","article-title":"Increased pain sensitivity in fibromyalgia: Effects of stimulus type and mode of presentation","volume":"105","author":"Petzke","year":"2003","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2023.05.003_bib33","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.pain.2009.03.018","article-title":"Evidence of dysfunctional pain inhibition in fibromyalgia reflected in rACC during provoked pain","volume":"144","author":"Jensen","year":"2009","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2023.05.003_bib34","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.sjpain.2011.10.003","article-title":"Experimental pressure-pain assessments: Test-retest reliability, convergence and dimensionality","volume":"3","author":"Lacourt","year":"2012","journal-title":"Scand J Pain"},{"key":"10.1016\/j.jpain.2023.05.003_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0182959","article-title":"Minimizing nocebo effects by conditioning with verbal suggestion: A randomized clinical trial in healthy humans","volume":"12","author":"Bartels","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jpain.2023.05.003_bib36","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1097\/j.pain.0000000000002820","article-title":"Placebo effects on cutaneous pain and itch: a systematic review and meta-analysis of experimental results and methodology","volume":"164","author":"Blythe","year":"2023","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2023.05.003_bib37","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.semarthrit.2016.08.012","article-title":"2016 Revisions to the 2010\/2011 fibromyalgia diagnostic criteria","volume":"46","author":"Wolfe","year":"2016","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.jpain.2023.05.003_bib38","first-page":"728","article-title":"The fibromyalgia impact questionnaire: Development and validation","volume":"18","author":"Burckhardt","year":"1991","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jpain.2023.05.003_bib39","series-title":"Manual for the Depression Anxiety Stress Scales","author":"Lovibond","year":"1995"},{"key":"10.1016\/j.jpain.2023.05.003_bib40","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1037\/0022-3514.67.6.1063","article-title":"Distinguishing optimism from neuroticism (and trait anxiety, self-mastery, and self-esteem): A reevaluation of the life orientation test","volume":"67","author":"Scheier","year":"1994","journal-title":"Artic J Personal Soc Psychol"},{"key":"10.1016\/j.jpain.2023.05.003_bib41","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1037\/1040-3590.7.4.524","article-title":"The pain catastrophizing scale: Development and validation","volume":"7","author":"Sullivan","year":"1995","journal-title":"Psychol Assess"},{"key":"10.1016\/j.jpain.2023.05.003_bib42","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1037\/0022-006X.65.2.214","article-title":"Body vigilance in panic disorder: Evaluating attention to bodily perturbations","volume":"65","author":"Schmidt","year":"1997","journal-title":"J Consult Clin Psychol"},{"key":"10.1016\/j.jpain.2023.05.003_bib43","doi-asserted-by":"crossref","first-page":"2","DOI":"10.2307\/2136319","article-title":"The structure of coping","volume":"19","author":"Pearlin","year":"1978","journal-title":"J Health Soc Behav"},{"key":"10.1016\/j.jpain.2023.05.003_bib44","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.2044-8260.1992.tb00997.x","article-title":"The development of a six-item short-form of the state scale of the Spielberger State\u2014Trait Anxiety Inventory (STAI)","volume":"31","author":"Marteau","year":"1992","journal-title":"Br J Clin Psychol"},{"key":"10.1016\/j.jpain.2023.05.003_bib45","series-title":"R: A Language and Environment for Statistical Computing","year":"2021"},{"key":"10.1016\/j.jpain.2023.05.003_bib46","series-title":"ANOVA: Repeated measures","author":"Girden","year":"1992"},{"key":"10.1016\/j.jpain.2023.05.003_bib47","series-title":"Discovering Statistics Using IBM SPSS Statistics","author":"Field","year":"2013"},{"key":"10.1016\/j.jpain.2023.05.003_bib48","first-page":"567","article-title":"Effects, nocebo communication, patient-clinician outcomes, therapeutic","volume":"307","author":"Colloca","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.jpain.2023.05.003_bib49","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.3389\/fphar.2019.01372","article-title":"The clinical implications of nocebo effects for biosimilar therapy","volume":"10","author":"Colloca","year":"2019","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jpain.2023.05.003_bib50","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/j.pain.0000000000002017","article-title":"An experimental investigation into the mediating role of pain-related fear in boosting nocebo hyperalgesia","volume":"162","author":"Thomaidou","year":"2021","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2023.05.003_bib51","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1097\/j.pain.0000000000001538","article-title":"A deeper look at pain variability and its relationship with the placebo response: Results from a randomized, double-blind, placebo-controlled clinical trial of naproxen in osteoarthritis of the knee","volume":"160","author":"Treister","year":"2019","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2023.05.003_bib52","doi-asserted-by":"crossref","first-page":"46","DOI":"10.2340\/00015555-0743","article-title":"Role of attentional focus on bodily sensations in sensitivity to itch and pain","volume":"90","author":"van Laarhoven","year":"2010","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jpain.2023.05.003_bib53","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.pneurobio.2013.02.003","article-title":"Pain and analgesia: The value of salience circuits","volume":"104","author":"Borsook","year":"2013","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.jpain.2023.05.003_bib54","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1080\/08964289.2015.1094442","article-title":"Diminished interoceptive awareness in fibromyalgia syndrome","volume":"43","author":"Duschek","year":"2017","journal-title":"Behav Med"},{"key":"10.1016\/j.jpain.2023.05.003_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnhum.2017.00117","article-title":"Exteroceptive and interoceptive body-self awareness in fibromyalgia patients","volume":"11","author":"Valenzuela-Moguillansky","year":"2017","journal-title":"Front Hum Neurosci"},{"key":"10.1016\/j.jpain.2023.05.003_bib56","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1101\/lm.77504","article-title":"Spontaneous recovery","volume":"11","author":"Rescorla","year":"2004","journal-title":"Learn Mem"},{"key":"10.1016\/j.jpain.2023.05.003_bib57","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.pain.2008.02.006","article-title":"The role of learning in nocebo and placebo effects","volume":"136","author":"Colloca","year":"2008","journal-title":"Pain"}],"container-title":["The Journal of Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526590023004133?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526590023004133?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:10:30Z","timestamp":1778616630000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526590023004133"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":57,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S1526590023004133"],"URL":"https:\/\/doi.org\/10.1016\/j.jpain.2023.05.003","relation":{},"ISSN":["1526-5900"],"issn-type":[{"value":"1526-5900","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nocebo Hyperalgesia in Patients With Fibromyalgia and Healthy Controls: An Experimental Investigation of Conditioning and Extinction Processes at Baseline and 1-Month Follow-up","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pain","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpain.2023.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc. on behalf of United States Association for the Study of Pain, Inc","name":"copyright","label":"Copyright"}]}}